​

Decoy Therapeutics Ownership | Who Owns Decoy Therapeutics?

OverviewFinancialsChart

Decoy Therapeutics Ownership Summary

Decoy Therapeutics is owned by 0.33% institutional investors, 0.59% insiders, and 99.08% retail investors.

DCOY Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockDecoy Therapeutics0.33%0.59%99.08%
SectorHealthcare Stocks 35.38%11.35%53.27%
IndustryBiotech Stocks 33.91%11.39%54.70%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20264-1,609---4---

Recent Insider Transactions

DateNameRoleActivityValue
Dec 30, 2025HANISH ARNOLD C-Sell$7.68
Dec 30, 2025HANISH ARNOLD C-Sell$9.60
Nov 20, 2025HANISH ARNOLD C-Buy$3.74K
Nov 20, 2025Rosenblum Mark J Exec VP Finance, CFOBuy$16.00K
Jun 07, 2022Burleson Tess Buy$4.99K

Insider Transactions Trends

DateBuySell
2025 Q41-
2024 Q2--
2024 Q1--
2023 Q1--
2022 Q4--

DCOY Ownership FAQ

Who Owns Decoy Therapeutics?

Decoy Therapeutics shareholders are primarily institutional investors at 0.33%, followed by 0.59% insiders and 99.08% retail investors. The average institutional ownership in Decoy Therapeutics's industry, Biotech Stocks , is 33.91%, which Decoy Therapeutics falls below.

Does Blackrock own Decoy Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Decoy Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools